Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), posted on LinkedIn:
“Excited to announce the kick-off meeting of our EU-funded project COMBAT-PDAC, held at Vall d’Hebron Institute of Oncology (VHIO) in Barcelona!
With nearly €2M from EP PerMed – the European Partnership for Personalised Medicine and support from ANR, the French National Research Agency, this project aims to tackle the complexity of pancreatic cancer by identifying and targeting diverse tumor subpopulations.
Together, we will:
1. Identify combinatorial biomarkers.
2. Develop monoclonal antibodies and CAR-T cells.
3. Uncover new diagnostic and therapeutic mechanisms.
Our consortium brings together six outstanding partners from four countries:
- TU Dresden – Prof. Michele Solimena
- HZDR – Dr. Anja Feldmann
- CRCM/INSERM – Dr. Nelson Dusetti
- IEO – Dr. Gioacchino Natoli
- IRB Barcelona – Dr. Direna Alonso Curbelo
- VHIO – Dr. Teresa Macarulla
Proud to contribute from the CRCM and Institute of Paoli-Calmettes in Marseille.
Let’s fight PDAC with innovation and collaboration!”